Vaccine composition preventing porcine reproductive and respiratory syndrome, preparation method and application thereof
A technology for respiratory syndrome and vaccine composition, which is applied in the field of vaccine composition and its preparation for the prevention of porcine reproductive and respiratory syndrome, can solve the problems of gene sequence changes, complex disease, and unsatisfactory re-prevention effect, and achieve improved Productivity, effects of good immunogenicity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment approach
[0019] As an embodiment of the present invention, the porcine reproductive and respiratory syndrome virus VR2332 strain antigen includes inactivated antigen, attenuated antigen, subunit antigen or synthetic peptide of porcine reproductive and respiratory syndrome virus VR2332 strain or its culture antigen.
[0020] As an embodiment of the present invention, the porcine reproductive and respiratory syndrome virus JXA1 strain antigen includes inactivated antigen, attenuated antigen, subunit antigen or synthetic peptide of porcine reproductive and respiratory syndrome virus JXA1 strain or its culture antigen.
[0021] As an embodiment of the present invention, the porcine reproductive and respiratory syndrome virus HNjz15 strain antigen includes inactivated antigen, attenuated antigen, subunit antigen or synthetic peptide of porcine reproductive and respiratory syndrome virus HNjz15 strain or its culture antigen.
[0022] As an embodiment of the present invention, the antigen o...
Embodiment 1
[0078] Preparation of Antigen of Porcine Reproductive and Respiratory Syndrome Virus JXA1 Strain
[0079] Inoculate the culture of porcine reproductive and respiratory syndrome virus JXA1 strain into Marc-145 cells, insert into the Marc-145 cell culture that forms a single layer according to 1% (V / V) of the virus culture solution, and culture at 37°C , 24-48 hours to harvest the toxic cell culture medium, centrifuge the cells into agglomerates, and discard the supernatant. The cell pellet was resuspended in 0.05M Tris(carboxymethyl)aminomethane 0.025MEDTA buffer containing 0.5% Triton X-100, and the volume of the buffer was 5-10 times that of the concentrated cells. The mixture was stirred at 4°C for 2-15 hours and centrifuged at 10000 g for 1 hour. Harvest the supernatant for later use.
Embodiment 2
[0081] Routine Preparation of Antigen of Porcine Reproductive and Respiratory Syndrome Virus JXA1 Strain
[0082] Inoculate the culture of porcine reproductive and respiratory syndrome virus JXA1 strain into Marc-145 cells, insert into the Marc-145 cell culture that forms a single layer according to 1% (V / V) of the virus culture solution, and culture at 37°C , when the lesion reaches 80%, harvest the toxic cell culture medium, after 2 times of freezing and thawing, collect the poison, and measure the poison price. Add 10% (v / v) formaldehyde solution to make the final concentration of formaldehyde to 0.2% (V / V), inactivate at 37°C for 18 hours, stir once every 4 hours, stir for 10min each time, and set aside after complete inactivation.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com